ATHERSYS, INC Business Operations Contracts & Agreements
63 Contracts & Agreements
- Agency Agreements (5 contracts)
- Collaboration Agreements (5)
- Cooperation Agreements (2)
- Development Agreements (47)
- Indemnification Agreements (1)
- MOUs (1)
- Settlement Agreements (1)
- Termination Agreements (1)
- Memorandum of Understanding, dated October 10, 2023, by and between ABT Holding Company and HEALIOS K.K (Filed With SEC on November 16, 2023)
- Forbearance, Restructuring and Settlement Agreement, dated as of May 17, 2023, between Athersys, Inc., certain subsidiaries of Athersys, Inc., and (Filed With SEC on August 16, 2023)
- Form of Placement Agency Agreement (Filed With SEC on August 7, 2023)
- Form of Placement Agency Agreement (Filed With SEC on July 26, 2023)
- Amendment to Cooperation Agreement, dated as of August 5, 2021, by and among Athersys, Inc. and HEALIOS K.K. and Dr. Tadahisa Kagimoto (Filed With SEC on November 15, 2021)
- Cooperation Agreement, dated as of February 16, 2021, by and among Athersys, Inc. and HEALIOS K.K. and Dr. Tadahisa Kagimoto (Filed With SEC on February 16, 2021)
- Amendment No. 3 to Collaboration Expansion Agreement, by and between Athersys, Inc. and HEALIOS K.K., dated as of December 14, 2018 (Filed With SEC on March 15, 2019)
- Amendment No. 2 to Collaboration Expansion Agreement, by and between Athersys, Inc. and HEALIOS K.K., dated as of December 6, 2018 (Filed With SEC on March 15, 2019)
- Amendment No. 1 to Collaboration Expansion Agreement, by and between Athersys, Inc. and HEALIOS K.K., dated as of August 31, 2018 (Filed With SEC on November 6, 2018)
- Collaboration Expansion Agreement, by and between Athersys, Inc. and HEALIOS K.K., dated as of June 6, 2018 (Filed With SEC on August 9, 2018)
- AMENDMENT No. 3 TO EXTENDED COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 14, 2012)
- TERMINATION AGREEMENT (Filed With SEC on November 14, 2011)
- Efficiently develop product candidates in established areas of significant clinical need. We are focused on the development of best-in-class product candidates with differentiated... (Filed With SEC on March 25, 2011)
- Efficiently develop product candidates in established areas of significant clinical need. We are focused on the development of best-in-class product candidates with differentiated... (Filed With SEC on March 25, 2011)
- Efficiently develop product candidates in established areas of significant clinical need. We are focused on the development of best-in-class product candidates with differentiated... (Filed With SEC on March 25, 2011)
- Placement Agency Agreement, dated as of January 27, 2011, by and among the Company and William Blair & Company, L.L.C. and First Analysis Securities Corporation (Filed With SEC on January 28, 2011)
- Placement Agency Agreement, dated as of January 27, 2011, by and among the Company and William Blair & Company, L.L.C. and First Analysis Securities Corporation (Filed With SEC on January 28, 2011)
- Placement Agency Agreement, dated as of January 27, 2011, by and among the Company and William Blair & Company, L.L.C. and First Analysis Securities Corporation (Filed With SEC on January 28, 2011)
- Efficiently develop product candidates in established areas of significant clinical need. We will continue to develop certain product candidates leveraging others prior clinical... (Filed With SEC on March 11, 2010)
- Efficiently develop product candidates in established areas of significant clinical need. We will continue to develop certain product candidates leveraging others prior clinical... (Filed With SEC on March 11, 2010)
- Efficiently develop product candidates in established areas of significant clinical need. We will continue to develop certain product candidates leveraging others prior clinical... (Filed With SEC on March 11, 2010)
- [DIRECTOR][OFFICER][DIRECTOR AND OFFICER] INDEMNIFICATION AGREEMENT (Filed With SEC on August 6, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on June 14, 2007)
